FindTrial
Sign In

Serology of patients with echinococcus and its implication for vaccine design

Serology of patients with echinococcus and its implication for vaccine design

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100050262
Enrollment
Unknown
Registered
2021-08-24
Start date
2021-09-15
Completion date
Unknown
Last updated
2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

echinococcosis

Interventions

Echinococcosis patients group:none
Healthy donor group:none

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients with alveolar and cystic echinococcosis; 2.Non-patients in the epidemic area; 3.Normal people in the non-endemic area (matched by age and sex).

Exclusion criteria

Exclusion criteria: None.

Design outcomes

Primary

MeasureTime frame
Type and level of serum antibody;—

Secondary

MeasureTime frame
Human leukocyte antigen phenotype;—

Countries

China

Contacts

Public ContactLiu Jie

West China Hospital of Sichuan University

liujie@wchscu.cn+86 18980606533

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026